 | • レポートコード：QYR2104Z2155 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、子宮内膜癌のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（子宮摘出術、放射線療法、ホルモン療法、化学療法）、用途別市場規模（病院、診療所、婦人科センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・子宮内膜癌の市場動向 ・企業の競争状況、市場シェア ・子宮内膜癌の種類別市場規模（子宮摘出術、放射線療法、ホルモン療法、化学療法） ・子宮内膜癌の用途別市場規模（病院、診療所、婦人科センター、その他） ・子宮内膜癌の北米市場規模2016-2027（アメリカ、カナダ） ・子宮内膜癌のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮内膜癌のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮内膜癌の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮内膜癌の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Johnson & Johnson、Boston Scientific、GE、Karl Storz、Koninklijke Philips、Celgene、Lupin、LiNA Medical、Bayer AG、Cooper Surgical、Hologic） ・結論 |
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.
Market Analysis and Insights: Global Endometrial Cancer Market
The global Endometrial Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometrial Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometrial Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometrial Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometrial Cancer market.
Global Endometrial Cancer Scope and Market Size
Endometrial Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endometrial Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hysterectomy Techniques
Radiation
Hormone Therapy
Chemotherapy
Segment by Application
Hospitals
Clinics
Gynecology Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Johnson & Johnson
Boston Scientific
GE
Karl Storz
Koninklijke Philips
Celgene
Lupin
LiNA Medical
GE
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometrial Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hysterectomy Techniques
1.2.3 Radiation
1.2.4 Hormone Therapy
1.2.5 Chemotherapy
1.3 Market by Application
1.3.1 Global Endometrial Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Gynecology Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endometrial Cancer Market Perspective (2016-2027)
2.2 Endometrial Cancer Growth Trends by Regions
2.2.1 Endometrial Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endometrial Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Endometrial Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Endometrial Cancer Industry Dynamic
2.3.1 Endometrial Cancer Market Trends
2.3.2 Endometrial Cancer Market Drivers
2.3.3 Endometrial Cancer Market Challenges
2.3.4 Endometrial Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endometrial Cancer Players by Revenue
3.1.1 Global Top Endometrial Cancer Players by Revenue (2016-2021)
3.1.2 Global Endometrial Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Endometrial Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endometrial Cancer Revenue
3.4 Global Endometrial Cancer Market Concentration Ratio
3.4.1 Global Endometrial Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometrial Cancer Revenue in 2020
3.5 Endometrial Cancer Key Players Head office and Area Served
3.6 Key Players Endometrial Cancer Product Solution and Service
3.7 Date of Enter into Endometrial Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endometrial Cancer Breakdown Data by Type
4.1 Global Endometrial Cancer Historic Market Size by Type (2016-2021)
4.2 Global Endometrial Cancer Forecasted Market Size by Type (2022-2027)
5 Endometrial Cancer Breakdown Data by Application
5.1 Global Endometrial Cancer Historic Market Size by Application (2016-2021)
5.2 Global Endometrial Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Endometrial Cancer Market Size (2016-2027)
6.2 North America Endometrial Cancer Market Size by Type
6.2.1 North America Endometrial Cancer Market Size by Type (2016-2021)
6.2.2 North America Endometrial Cancer Market Size by Type (2022-2027)
6.2.3 North America Endometrial Cancer Market Size by Type (2016-2027)
6.3 North America Endometrial Cancer Market Size by Application
6.3.1 North America Endometrial Cancer Market Size by Application (2016-2021)
6.3.2 North America Endometrial Cancer Market Size by Application (2022-2027)
6.3.3 North America Endometrial Cancer Market Size by Application (2016-2027)
6.4 North America Endometrial Cancer Market Size by Country
6.4.1 North America Endometrial Cancer Market Size by Country (2016-2021)
6.4.2 North America Endometrial Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Endometrial Cancer Market Size (2016-2027)
7.2 Europe Endometrial Cancer Market Size by Type
7.2.1 Europe Endometrial Cancer Market Size by Type (2016-2021)
7.2.2 Europe Endometrial Cancer Market Size by Type (2022-2027)
7.2.3 Europe Endometrial Cancer Market Size by Type (2016-2027)
7.3 Europe Endometrial Cancer Market Size by Application
7.3.1 Europe Endometrial Cancer Market Size by Application (2016-2021)
7.3.2 Europe Endometrial Cancer Market Size by Application (2022-2027)
7.3.3 Europe Endometrial Cancer Market Size by Application (2016-2027)
7.4 Europe Endometrial Cancer Market Size by Country
7.4.1 Europe Endometrial Cancer Market Size by Country (2016-2021)
7.4.2 Europe Endometrial Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Endometrial Cancer Market Size (2016-2027)
8.2 Asia-Pacific Endometrial Cancer Market Size by Type
8.2.1 Asia-Pacific Endometrial Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endometrial Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endometrial Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Endometrial Cancer Market Size by Application
8.3.1 Asia-Pacific Endometrial Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endometrial Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endometrial Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Endometrial Cancer Market Size by Region
8.4.1 Asia-Pacific Endometrial Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endometrial Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Endometrial Cancer Market Size (2016-2027)
9.2 Latin America Endometrial Cancer Market Size by Type
9.2.1 Latin America Endometrial Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Endometrial Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Endometrial Cancer Market Size by Type (2016-2027)
9.3 Latin America Endometrial Cancer Market Size by Application
9.3.1 Latin America Endometrial Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Endometrial Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Endometrial Cancer Market Size by Application (2016-2027)
9.4 Latin America Endometrial Cancer Market Size by Country
9.4.1 Latin America Endometrial Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Endometrial Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endometrial Cancer Market Size (2016-2027)
10.2 Middle East & Africa Endometrial Cancer Market Size by Type
10.2.1 Middle East & Africa Endometrial Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endometrial Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endometrial Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Endometrial Cancer Market Size by Application
10.3.1 Middle East & Africa Endometrial Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endometrial Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endometrial Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Endometrial Cancer Market Size by Country
10.4.1 Middle East & Africa Endometrial Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endometrial Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Endometrial Cancer Introduction
11.1.4 Pfizer Revenue in Endometrial Cancer Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Endometrial Cancer Introduction
11.2.4 Johnson & Johnson Revenue in Endometrial Cancer Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Endometrial Cancer Introduction
11.3.4 Boston Scientific Revenue in Endometrial Cancer Business (2016-2021)
11.3.5 Boston Scientific Recent Development
11.4 GE
11.4.1 GE Company Details
11.4.2 GE Business Overview
11.4.3 GE Endometrial Cancer Introduction
11.4.4 GE Revenue in Endometrial Cancer Business (2016-2021)
11.4.5 GE Recent Development
11.5 Karl Storz
11.5.1 Karl Storz Company Details
11.5.2 Karl Storz Business Overview
11.5.3 Karl Storz Endometrial Cancer Introduction
11.5.4 Karl Storz Revenue in Endometrial Cancer Business (2016-2021)
11.5.5 Karl Storz Recent Development
11.6 Koninklijke Philips
11.6.1 Koninklijke Philips Company Details
11.6.2 Koninklijke Philips Business Overview
11.6.3 Koninklijke Philips Endometrial Cancer Introduction
11.6.4 Koninklijke Philips Revenue in Endometrial Cancer Business (2016-2021)
11.6.5 Koninklijke Philips Recent Development
11.7 Celgene
11.7.1 Celgene Company Details
11.7.2 Celgene Business Overview
11.7.3 Celgene Endometrial Cancer Introduction
11.7.4 Celgene Revenue in Endometrial Cancer Business (2016-2021)
11.7.5 Celgene Recent Development
11.8 Lupin
11.8.1 Lupin Company Details
11.8.2 Lupin Business Overview
11.8.3 Lupin Endometrial Cancer Introduction
11.8.4 Lupin Revenue in Endometrial Cancer Business (2016-2021)
11.8.5 Lupin Recent Development
11.9 LiNA Medical
11.9.1 LiNA Medical Company Details
11.9.2 LiNA Medical Business Overview
11.9.3 LiNA Medical Endometrial Cancer Introduction
11.9.4 LiNA Medical Revenue in Endometrial Cancer Business (2016-2021)
11.9.5 LiNA Medical Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Endometrial Cancer Introduction
11.10.4 Bayer AG Revenue in Endometrial Cancer Business (2016-2021)
11.10.5 Bayer AG Recent Development
11.11 Cooper Surgical
11.11.1 Cooper Surgical Company Details
11.11.2 Cooper Surgical Business Overview
11.11.3 Cooper Surgical Endometrial Cancer Introduction
11.11.4 Cooper Surgical Revenue in Endometrial Cancer Business (2016-2021)
11.11.5 Cooper Surgical Recent Development
11.12 Hologic
11.12.1 Hologic Company Details
11.12.2 Hologic Business Overview
11.12.3 Hologic Endometrial Cancer Introduction
11.12.4 Hologic Revenue in Endometrial Cancer Business (2016-2021)
11.12.5 Hologic Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Endometrial Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hysterectomy Techniques
Table 3. Key Players of Radiation
Table 4. Key Players of Hormone Therapy
Table 5. Key Players of Chemotherapy
Table 6. Global Endometrial Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endometrial Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endometrial Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endometrial Cancer Market Share by Regions (2016-2021)
Table 10. Global Endometrial Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endometrial Cancer Market Share by Regions (2022-2027)
Table 12. Endometrial Cancer Market Trends
Table 13. Endometrial Cancer Market Drivers
Table 14. Endometrial Cancer Market Challenges
Table 15. Endometrial Cancer Market Restraints
Table 16. Global Endometrial Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endometrial Cancer Market Share by Players (2016-2021)
Table 18. Global Top Endometrial Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometrial Cancer as of 2020)
Table 19. Ranking of Global Top Endometrial Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endometrial Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometrial Cancer Product Solution and Service
Table 23. Date of Enter into Endometrial Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometrial Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endometrial Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Endometrial Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endometrial Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endometrial Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endometrial Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Endometrial Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endometrial Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endometrial Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endometrial Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endometrial Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endometrial Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endometrial Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endometrial Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endometrial Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endometrial Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endometrial Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endometrial Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endometrial Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endometrial Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endometrial Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endometrial Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endometrial Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endometrial Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endometrial Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endometrial Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endometrial Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endometrial Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endometrial Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endometrial Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endometrial Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endometrial Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endometrial Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endometrial Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endometrial Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endometrial Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endometrial Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endometrial Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Endometrial Cancer Product
Table 66. Pfizer Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Endometrial Cancer Product
Table 71. Johnson & Johnson Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Boston Scientific Company Details
Table 74. Boston Scientific Business Overview
Table 75. Boston Scientific Endometrial Cancer Product
Table 76. Boston Scientific Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 77. Boston Scientific Recent Development
Table 78. GE Company Details
Table 79. GE Business Overview
Table 80. GE Endometrial Cancer Product
Table 81. GE Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 82. GE Recent Development
Table 83. Karl Storz Company Details
Table 84. Karl Storz Business Overview
Table 85. Karl Storz Endometrial Cancer Product
Table 86. Karl Storz Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 87. Karl Storz Recent Development
Table 88. Koninklijke Philips Company Details
Table 89. Koninklijke Philips Business Overview
Table 90. Koninklijke Philips Endometrial Cancer Product
Table 91. Koninklijke Philips Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 92. Koninklijke Philips Recent Development
Table 93. Celgene Company Details
Table 94. Celgene Business Overview
Table 95. Celgene Endometrial Cancer Product
Table 96. Celgene Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 97. Celgene Recent Development
Table 98. Lupin Company Details
Table 99. Lupin Business Overview
Table 100. Lupin Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 101. Lupin Recent Development
Table 102. LiNA Medical Company Details
Table 103. LiNA Medical Business Overview
Table 104. LiNA Medical Endometrial Cancer Product
Table 105. LiNA Medical Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 106. LiNA Medical Recent Development
Table 107. Bayer AG Company Details
Table 108. Bayer AG Business Overview
Table 109. Bayer AG Endometrial Cancer Product
Table 110. Bayer AG Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 111. Bayer AG Recent Development
Table 112. Cooper Surgical Company Details
Table 113. Cooper Surgical Business Overview
Table 114. Cooper Surgical Endometrial Cancer Product
Table 115. Cooper Surgical Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 116. Cooper Surgical Recent Development
Table 117. Hologic Company Details
Table 118. Hologic Business Overview
Table 119. Hologic Endometrial Cancer Product
Table 120. Hologic Revenue in Endometrial Cancer Business (2016-2021) & (US$ Million)
Table 121. Hologic Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometrial Cancer Market Share by Type: 2020 VS 2027
Figure 2. Hysterectomy Techniques Features
Figure 3. Radiation Features
Figure 4. Hormone Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Global Endometrial Cancer Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Gynecology Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Endometrial Cancer Report Years Considered
Figure 12. Global Endometrial Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Endometrial Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Endometrial Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Endometrial Cancer Market Share by Regions (2022-2027)
Figure 16. Global Endometrial Cancer Market Share by Players in 2020
Figure 17. Global Top Endometrial Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometrial Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Endometrial Cancer Revenue in 2020
Figure 19. Global Endometrial Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Endometrial Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Endometrial Cancer Market Share by Type (2016-2027)
Figure 23. North America Endometrial Cancer Market Share by Application (2016-2027)
Figure 24. North America Endometrial Cancer Market Share by Country (2016-2027)
Figure 25. United States Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Endometrial Cancer Market Share by Type (2016-2027)
Figure 29. Europe Endometrial Cancer Market Share by Application (2016-2027)
Figure 30. Europe Endometrial Cancer Market Share by Country (2016-2027)
Figure 31. Germany Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Endometrial Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Endometrial Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Endometrial Cancer Market Share by Region (2016-2027)
Figure 41. China Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Endometrial Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Endometrial Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Endometrial Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Endometrial Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Endometrial Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Endometrial Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Endometrial Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 62. Boston Scientific Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 63. GE Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 64. Karl Storz Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 65. Koninklijke Philips Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 66. Celgene Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 67. Lupin Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 68. LiNA Medical Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 69. Bayer AG Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 70. Cooper Surgical Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 71. Hologic Revenue Growth Rate in Endometrial Cancer Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の子宮内膜がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Endometrial Cancer Therapeutics Market The global Endometrial Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界の子宮内膜アブレーション市場規模・現状・予測（2021年-2027年） Endometrial ablation is a non-invasive procedure which results in destruction of or ablation of the outermost lining of uterus called endometrium. The endometrial ablation is essentially used in the treatment of abnormal uterine bleeding. In addition, prolonged abnormal uterine bleeding can result i…
- 世界の子宮内膜生検用ブラシ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Endometrial Biopsy Brush Market The global Endometrial Biopsy Brush market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の子宮鏡子宮内膜切除術市場規模・現状・予測（2021年-2027年） The process in which endometrial lining of the womb (uterus) is removed or destroyed is referred as hysteroscopic endometrial resection procedures. This procedure is also referred as transcervical resection of endometrium (TCRE). Hysteroscopic endometrial resection procedure is very effective treatm…
- 世界の子宮鏡による子宮内膜切除処置市場 2021：企業別、地域別、種類・用途別 The Hysteroscopic Endometrial Resection Procedures market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…